Načítá se...
Prescription Stimulant Medication Misuse: Where Are We and Where Do We Go from Here?
Prescription stimulants, including methylphenidate (e.g., Ritalin) and amphetamine compounds (e.g., dextroamphetamine; Adderall), have been approved by the U.S. Food and Drug Administration for the treatment of attention deficit hyperactivity disorder (ADHD) and are classified by the United States D...
Uloženo v:
| Vydáno v: | Exp Clin Psychopharmacol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5113141/ https://ncbi.nlm.nih.gov/pubmed/27690507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1037/pha0000093 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|